CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,476,810
-25.1%
781,328
+17.4%
0.00%0.0%
Q2 2023$3,306,695
+2.9%
665,331
+2.3%
0.00%0.0%
Q1 2023$3,212,408
-21.3%
650,285
+0.2%
0.00%0.0%
Q4 2022$4,080,921
-40.5%
648,795
+2.1%
0.00%
-50.0%
Q3 2022$6,863,000
+10.6%
635,455
+16.8%
0.00%0.0%
Q2 2022$6,203,000
+28.3%
544,109
+2.5%
0.00%
+100.0%
Q1 2022$4,835,000
-39.7%
530,659
-1.2%
0.00%
-50.0%
Q4 2021$8,013,000
-41.3%
537,045
+1.1%
0.00%
-50.0%
Q3 2021$13,647,000
-17.5%
530,996
-16.3%
0.00%
-20.0%
Q2 2021$16,545,000
-16.8%
634,369
+12.7%
0.01%
-28.6%
Q1 2021$19,876,000
+43.2%
563,054
+2.4%
0.01%
+16.7%
Q4 2020$13,883,000
-31.8%
550,007
+1.9%
0.01%
-33.3%
Q3 2020$20,359,000
-10.4%
539,883
+1.7%
0.01%
-18.2%
Q2 2020$22,732,000
+190.8%
530,866
+32.0%
0.01%
+120.0%
Q1 2020$7,818,000
-23.9%
402,153
+1.7%
0.01%
-16.7%
Q4 2019$10,274,000
-2.6%
395,447
+2.2%
0.01%0.0%
Q3 2019$10,543,000
+105.2%
386,820
+102.2%
0.01%
+100.0%
Q2 2019$5,138,000
+16.3%
191,343
+25.3%
0.00%0.0%
Q1 2019$4,417,000
+13.8%
152,764
+6.0%
0.00%0.0%
Q4 2018$3,882,000144,1270.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders